Innovative Technology Silk Therapeutics has pioneered a proprietary Liquid Silk Technology and Activated Silk™ technology, emphasizing their focus on advanced, science-backed skincare solutions. This presents opportunities to collaborate or supply raw silk proteins and related ingredients to enhance their product innovation pipeline.

Luxury Market Focus With exclusive product launches at Harrods and a luxury positioning, there is potential to explore high-end retail partnerships, private label collaborations, or premium ingredient supply opportunities tailored to upscale consumers seeking clean, effective skincare products.

Growing Financial Backing Having secured $30 million in funding with current revenues between $1 million and $10 million indicates strong investor confidence and growth potential, making them receptive to strategic partnerships, investment, or supply chain enhancements to increase market reach.

Research & Development Focus Recent hiring of a Director of R&D for skincare indicates ongoing product innovation and scientific validation, creating opportunities to offer research collaborations, laboratory ingredients, or innovative delivery systems that align with their development goals.

Market Expansion Potential Positioned within the biotechnology research industry with a unique silk-based approach, Silk Therapeutics is poised for expansion into medical, research, and wellness markets, opening avenues for supplying silk biomolecules, clinical testing services, or technology licensing to support their growth.